Skip to main content
. 2012 Nov;56(11):5865–5874. doi: 10.1128/AAC.01411-12

Fig 9.

Fig 9

Efficacy of AFN-1252 in a mouse sepsis model. The in vivo efficacy of AFN-1252 was demonstrated in an acute lethal mouse S. aureus Smith infection model. Thirty minutes after intraperitoneal inoculation with a lethal dose of S. aureus Smith, an oral dose of AFN-1252 or linezolid was administered and percent survival was recorded over 5 days.